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A B S T R A C T
We report the case of an immunocompetent child with spondylodiscitis as a result of staphylococcal
sepsis, which was successfully treated with linezolid. The patient was admitted with fever and
circumferential swelling in the paradorsal region, which was evident only in the ﬂexed back position. A
chest X-ray showed a pleural effusion with pneumonitis and dorsal kyphosis. Following the yield of
Staphylococcus aureus from blood cultures, the initial therapy of ceftriaxone and amikacin was changed
to vancomycin. However, the dorsal swelling increased further and imaging investigations showed
destruction of the vertebral bodies D8–D10 and surrounding tissue swelling. Vancomycin was changed
to linezolid, and the patient began to improve; a full recovery was made. Our case suggests that even if
spondylodiscitis is rare in the pediatric age-group, particularly as a complication of staphylococcal
sepsis, early diagnosis and prompt and appropriate therapy are important to prevent severe
complications.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
journa l homepage: www.e lsev ier .com/ locate / i j id1. Introduction
Pediatric spondylodiscitis is an uncommon entity, accounting
for only 1–2% of all children with osteomyelitis, however the exact
incidence is unclear.1–4 The pathophysiology of child discitis and
vertebral osteomyelitis remains poorly understood. It is less
commonly seen in children younger than 3 years of age than in
adolescents and adults, because the vertebral bodies of infants
have a larger network of interosseous collateral arteries, which
help clear bacteria.5–8 At the same time, the relatively thin cortex
and loosely applied periosteum are poor barriers to the spread of
infection, hence young infants may be at risk of infection by less
virulent organisms, which are often part of the normal ﬂora in
humans.3,7,8 This is largely due to the poorly developed immune
system of young infants, who are less able to build up a speciﬁc
immune response. Staphylococcus aureus is the most common
cause of osteomyelitis in all age groups on account of its peculiar
tropism for bone tissue. The clinical efﬁcacy of linezolid has
previously been evaluated for staphylococcal osteoarticular
infections in children.9 Early diagnosis and appropriate therapy
are crucial, both for survival and the prevention of long-term
damage.3,8,10,11 We report the case of a young infant with
spondylodiscitis and sepsis by S. aureus.* Corresponding author. Tel.: +39 06 68592020; fax: +39 06 68592508.
E-mail address: krzy@opbg.net (A. Krzysztoﬁak).
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A 45-day-old male infant, born by uncomplicated delivery at
term, was admitted because of fever persisting for 24 h. There was
no history of trauma, skin infection, central venous catheter,
surgical or other invasive procedures. Two weeks before, the child
had presentedwith pharyngitis treatedwith amoxicillin for 6 days.
On physical examination, the patient was pale with a
hyperemic pharynx and a non-tender circumferential swelling
of 3 cm in diameter in the paradorsal region, which was evident in
the ﬂexed back position. Laboratory investigations showed a
leukocyte count of 31.39  109/l with 75.1% polymorphonuclear
neutrophils, hemoglobin (Hb) level of 9.9 g/dl, platelet count of 567
 109/l, C-reactive protein (CRP) of 27.83 mg/dl (normal value
<0.5), erythrocyte sedimentation rate (ESR) of 127 mm/h, and
increased levels of g-glutamyltransferase (g-GT <0.84 IU/l) and
ﬁbrinogen (675 mg/dl). Immunological investigations revealed
increased levels of immunoglobulins (IgG 2169, IgM 149, IgA
323 mg/dl) and normal T-cell subsets. At admission, cultures of
cerebrospinal ﬂuid, urine and blood were negative. Radiographic
examinations showed a pleural effusion with pneumonitis and
dorsal kyphosis. Antibiotic treatment with amikacin and ceftriax-
one was not followed by clinical improvement, and the child
developed increased inﬂammatory indices (CRP 37 mg/dl, ERS
140 mm/h) and anemia (Hb 7.2 g/dl), which required a blood
transfusion. Five days after admission, blood cultures yielded a
methicillin-sensitive S. aureus (MSSA), resistant to ampicillin.ses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Thoracic (D8–D10) spondylodiscitis: magnetic resonance image at admission.
Figure 2. Thoracic spondylodiscitis: magnetic resonance image after 2 years of
follow-up.
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tory concentration (MIC) of <2mg/ml. Therefore, intravenous
vancomycin was started (40 mg/kg divided into four daily doses).
Following vancomycin treatment, the patient became afebrile and
his leukocyte count (16.28  109/l, neutrophils 63%), ESR (85 mm/
h) and CRP (15.5 mg/dl) decreased.
Nevertheless, the dorsal swelling increased in size, while
ultrasound examination revealed a paravertebral inﬂammation. X-
ray showed a reduced pulmonary inﬁltrate and a disk narrowing of
the D8–D9 space. Computed tomography (CT) of the spine revealed
rarefaction of the body of D9, with the infection spreading into the
surrounding tissue. Bone scintigraphy, performed in order to
detectmultiple foci of infection, revealed increased signal intensity
at the body and at the endplate of D9. Contrast-enhancedmagnetic
resonance imaging (MRI) showed destruction of D8, D9 and D10
with increased signal intensity in the sagittal T2-weighted image
and tumefaction of surrounding tissue (Figure 1). Biopsy of the
D8–D9 disc space was performed, but aerobic, anaerobic, fungal
and mycobacterial culture failed to grow from the specimen.
Histopathological examination revealed granulation tissue con-
taining necrotic bone fragments and and inﬂammatory cells. After
the exclusion of Langerhans cell histiocytosis and infantile
myoﬁbromatosis, an inﬂammatory process was conﬁrmed.
About three weeks after starting vancomycin therapy, a sudden
and progressive worsening of the clinical condition, with fever and
a mild increment in the inﬂammatory indices (CRP 18 mg/dl, ESR
110 mm/h, white blood cell count 18.7  109/l with 75%
polymorphonuclear neutrophils), was registered. A CT scan was
performed and it showed no improvement in the lesions
previously described. We suspected a therapeutic failure. A blood
culturewas performed and it showed no growth.We did not repeat
a biopsy of the lesion. Taking into account the susceptibility to
vancomycin of the previously isolated specimen, we thought that
this failure could be ascribed to a low concentration of vancomycin
in osteoarticular lesions. Considering both the susceptibility of the
isolate to linezolid (MIC <0.5 mg/ml) and the high penetration of
this molecule into the osteoarticular tissue, we decided to
substitute vancomycin with linezolid, at a dosage of 30 mg/kg
divided into three daily doses. This led to a reduction in the
inﬂammatory indices and to a decrease of signal intensity in the
sagittal T2-weighted image.As a result of the improvement in clinical condition and in both
the radiological and the laboratory ﬁndings, we decided to
discontinue treatment after 27 days. Our choice not to continue
the treatmentwas due to our limited experiencewith linezolid and
to the risk of side effects in the case of a prolonged therapy. No
diarrhea, hematological disorders, or other side effects were
observed during the linezolid therapy.
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carried out. Two years later, step-wise bony consolidation of the
vertebral defect and partial remodeling was observed (Figure 2).
3. Discussion
Spondylodiscitis may be a complication of any systemic
infection, but is frequently a primary solitary focus of disease.
All types ofmicroorganisms, including viruses, parasites, fungi, and
bacteria, can cause spondylodiscitis.3,7,8,12–15 S. aureus is respon-
sible for 80–90% of cases of pyogenic osteomyelitis.2,7,8 Its
propensity to infect the bone may be related to the fact that it
expresses receptors for bone matrix components such as collagen,
thereby facilitating its adherence to bone tissue.7,8,16,17 S. aureus
can reach the bone by hematogenous spread, by extension from a
contiguous site, and secondary to vascular insufﬁciency.8 In our
case, we could not ﬁnd a primary source of infection, considering
that there was neither evidence of skin superinfection nor history
of trauma, central venous catheter, surgical or other invasive
procedures. Although biopsy of theD8–D9 disc spacewas negative,
blood cultures taken from a peripheral vein during an episode of
fever became positive for S. aureus. In our patient, an MRI study of
the spine appeared to be the best imaging study to evaluate
possible vertebral osteomyelitis evolving from a discitis.5,7,8,18
Blood cultures and more invasive procedures, including bone
biopsy, should strongly be considered in patients with suspected
vertebral osteomyelitis, where deﬁnition of a causal agent is
particularly important for a correct selection of the appropriate
antimicrobial therapy. Antibiotics were selected on the basis of the
susceptibility testing. The ﬁrst choice was vancomycin, which
initially performed well: the patient underwent a consistent
clinical improvement. However, after three weeks of therapy we
observed a sudden worsening of the clinical condition of the
patient, conﬁrmed by imaging studies of the lesion. Possible
explanations of this therapeutic failure could be a low concentra-
tion of vancomycin in osteoarticular lesions.
Linezolid is not approved for the therapy of osteoarticular
infections, but on account of the high concentrations it can attain in
osteoarticular tissue, andconsideringpositive evidence fromstudies
conducted in adult patients, it could be considered a good choice for
pediatric bone and joint infections.9 More studies are needed to
conﬁrm this observation. At the time of the clinical case described,
our choice was probably not completely evidence-based, and ananti-staphylococcal penicillin or a ﬁrst-generation cephalosporin
would have been preferred.
Even if spondylodiscitis in the pediatric age-group is an
extremely rare condition, it has to be considered in the differential
diagnosis since an early diagnosis and an appropriate therapy are
important to prevent potential complications, such as chronic
infection, vascular necrosis, growth abnormalities, and neurolo-
gical complications.7,8,10,11
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